Health Care Corporate Finance & Securities

A competitive global economy and constantly changing regulations are some of the driving forces behind your investment decisions. When it comes to corporate finance and securities, you need well-versed lawyers you can rely on to help you navigate this complex landscape.

As one of the country’s largest groups of securities attorneys dedicated to the health care industry, the depth of our knowledge allows us to effectively manage corporate finance and securities processes for many different transactions. We have extensive experience providing services to financial institutions, private equity firms, public and private companies, and other types of investors in the health care industry.

We act as your facilitators. Our attorneys have the technical know-how to handle the most sophisticated offerings. We have particular insight into many of the securities rules and regulations through members of our firm who have served at the Securities and Exchange Commission, including as chief of the SEC’s Office of Mergers and Acquisitions. Our integrated process involves identifying potential risks, ensuring regulatory compliance, and most importantly, providing and implementing solutions that protect the value of your deal.

Our services include:

• Initial public offerings
• High-yield and investment-grade public debt offerings
• Venture capital financing
• Acquisition and mezzanine financing
• Registered exchange offers
• Tender offers
• Shelf registrations and takedowns
• Recapitalizations
• Private placements

• Represented a large biotechnology company in its $250 million public offering of common stock.
• Represented a clinical-stage biopharmaceutical company in its underwritten public offering of 45 million shares of its common stock.
• Advised a nationwide post-acute care partner for hospitals, physicians, and families in a securities class action.
• Represented one of the nation's largest providers of post-acute health care services in its issuance of two tranches of senior secured notes.
• Advised a U.S. operator of health care facilities in equity and debt financing transactions.
• Represented a global medical technology company in a complex, tax-advantaged, multijurisdictional recapitalization and multibillion-dollar debt restructuring.
• Served as counsel to the spinoff company, a medical technology manufacturer, in the spinoff of Kimberly-Clark Corporation’s health care business. The spinoff required a complex restructuring of Kimberly-Clark’s health care business and involved a significant debt financing and related cash distribution to Kimberly-Clark.
• Represented a Florida medical distributor in its $2.1 billion acquisition by McKesson. In the deal, McKesson paid the acquired company’s shareholders $29 per share in cash, a 34 percent premium over the closing price of its stock the day before the public announcement. The cash consideration covered about $1.46 billion of the total purchase price, with the rest representing assumed debt.
• Represented AOTI Inc, the global leader in multimodality topical wound oxygen therapy, in its initial public offering on the London Stock Exchange’s AIM with a market capitalization on admission of £140m.